Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. (BIO) Revenue
Annual & quarterly revenue history · segment & region breakdown
BIO · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBio-Rad Laboratories, Inc. trailing twelve-month (TTM) revenue is $2.59B, an increase of 0.65% year-over-year from $2.58B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $2.58B | +$0.02B | +0.65% |
| 2024-12-31 | $2.57B | -$0.10B | -3.92% |
| 2023-12-31 | $2.67B | -$0.13B | -4.67% |
| 2022-12-31 | $2.80B | -$0.12B | -4.12% |
| 2021-12-31 | $2.92B | +$0.38B | +14.81% |
| 2020-12-31 | $2.55B | +$0.23B | +10.12% |
| 2019-12-31 | $2.31B | +$0.02B | +0.94% |
| 2018-12-31 | $2.29B | +$0.13B | +6.02% |
| 2017-12-31 | $2.16B | +$0.09B | +4.45% |
| 2016-12-31 | $2.07B | +$0.05B | +2.41% |
Compare revenue vs peers
Medical - DevicesCompare BIO revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Bio-Rad Laboratories, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Bio-Rad Laboratories, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Bio-Rad Laboratories, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BIO revenue · 4 questionsBIO's trailing twelve-month (TTM) revenue is $2.59B. That is an increase of 0.65% year-over-year from $2.58B in FY2025.
▸ Source: FMP · Bio-Rad Laboratories, Inc. SEC filings · GAAP · Bio-Rad Laboratories, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026